Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01394328 · ClinicalTrials.gov registry record
Delirium in Persons With Dementia
A clinical trial of Delirium Superimposed on Dementia, sponsored by Penn State University.
- Completed
- Registry status
- 308
- Enrollment target
- 1
- Study location
NCT01394328: Completed study of Delirium Superimposed on Dementia, sponsored by Penn State University.
NCT01394328 is a study of Delirium Superimposed on Dementia that has completed, run by Penn State University. The registered enrollment target is 308 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01394328, a study of Delirium Superimposed on Dementia, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- 308 participants
- Enrollment target
- 1
- Study location
Study Summary
The aims of this study were to identify risk factors associated with delirium in hospitalized persons with dementia, and to describe immediate and post-hospital (1\&3 months) trajectory of cognitive decline and associated outcomes in persons with dementia who develop delirium. It was hypothesized that factors such as CNS-active medications, urinary tract infection, stage of dementia, pain, activity level, and dehydration would be associated with an increased risk of delirium and delirium severity in patients with dementia compared to dementia patients without delirium. It was also hypothesized that persons with DSD will have worse outcomes (longer hospital length of stays, decreased functional status, a steeper negative slope of cognitive decline) than dementia patients without delirium. Lastly, it was hypothesized that higher delirium severity would be associated with poorer outcomes in persons with dementia. The long-term objectives were to use the results from this study to design and test an intervention strategy to improve early recognition, management, prevention, and outcomes in persons with DSD.
Primary Outcome
Confusion Assessment Method (CAM)and Delirium Rating Scale (DRS) were used to measure delirium.
Conditions Studied
Study Locations (1)
Pennsylvania
- Mount Nittany Medical Center - State College
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 308 participants |
| Start Date | 2006-04 |
| Est. Completion | 2008-11 |
What the finished NCT01394328 record still lists
NCT01394328 is an observational study that tracks outcomes without assigning an intervention. The registered 308 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Delirium Superimposed on Dementia appearing as the primary indexed condition, and to 0 interventions.
NCT01394328 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01394328 about?
NCT01394328 is a clinical study titled "Delirium in Persons With Dementia". The aims of this study were to identify risk factors associated with delirium in hospitalized persons with dementia, and to describe immediate and post-hospital (1\&3 months) trajectory of cognitive decline and associated outcomes in persons with dementia who develop delirium. It was hypothesized th...
What is the current status of trial NCT01394328?
This trial is currently completed. The enrollment target is 308 participants. The study started on 2006-04. Estimated completion is 2008-11.
What conditions does trial NCT01394328 study?
This clinical trial studies the following conditions: Delirium Superimposed on Dementia.
Who is sponsoring clinical trial NCT01394328?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01394328 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Delirium Superimposed on Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04162938 · 308 participants · NA
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
- NCT04955795 · 308 participants · NA
Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA
- NCT06090539 · 308 participants · Phase 1
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
- NCT06233942 · 308 participants · Phase 1
Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia